tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Shanghai Henlius Biotech’s HLX37 Receives IND Approval for Phase 1 Trials
PremiumCompany AnnouncementsShanghai Henlius Biotech’s HLX37 Receives IND Approval for Phase 1 Trials
7d ago
Shanghai Henlius Initiates Phase 1 Study of HLX13 for Liver Cancer
Premium
Company Announcements
Shanghai Henlius Initiates Phase 1 Study of HLX13 for Liver Cancer
13d ago
Shanghai Henlius Biotech’s HANSIZHUANG Receives Breakthrough Therapy Designation
Premium
Company Announcements
Shanghai Henlius Biotech’s HANSIZHUANG Receives Breakthrough Therapy Designation
18d ago
Shanghai Henlius Biotech’s HLX13 Receives FDA Approval for Clinical Trial
PremiumCompany AnnouncementsShanghai Henlius Biotech’s HLX13 Receives FDA Approval for Clinical Trial
2M ago
Shanghai Henlius Initiates Global Trial for Cancer Treatment Biosimilar
Premium
Company Announcements
Shanghai Henlius Initiates Global Trial for Cancer Treatment Biosimilar
2M ago
Shanghai Henlius Biotech Gains EU Approval for Osteoporosis Treatments
Premium
Company Announcements
Shanghai Henlius Biotech Gains EU Approval for Osteoporosis Treatments
3M ago
Shanghai Henlius Biotech Announces Board Composition and Roles
PremiumCompany AnnouncementsShanghai Henlius Biotech Announces Board Composition and Roles
3M ago
Shanghai Henlius Biotech Grants Options and RSUs to Boost Performance
Premium
Company Announcements
Shanghai Henlius Biotech Grants Options and RSUs to Boost Performance
3M ago
Shanghai Henlius Biotech: Strong Financial Performance and Promising Product Pipeline Drive Buy Rating
Premium
Ratings
Shanghai Henlius Biotech: Strong Financial Performance and Promising Product Pipeline Drive Buy Rating
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100